Clinical Data and Safety Management Center for NIAID
Official title: RhoFED CDSMC
Funded at Rho Federal Systems Division, INC. · NIH-11319865 · Data updated 2026-11-12
A centralized service that helps manage and safeguard allergy, asthma, autoimmune, and transplant-related clinical research for patients and clinicians.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rho Federal Systems Division, INC. NIH-funded |
| Lab location | 1 site (Durham, UNITED STATES) |
| Project start | May 8, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $9,116,252 |
| NIH project number | 5U01AI178773-04 |
| Project ID | NIH-11319865 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with allergic diseases, asthma, or autoimmune conditions who may participate in NIAID-funded trials or give biospecimens as part of future research.
✕Less likely to help
Patients not enrolled in NIAID-funded trials or not contributing biospecimens may not directly benefit from this center’s activities.
What this research studies
This grant funds a dedicated center that partners with NIAID to streamline how clinical trials are run, focusing on data management, safety reporting, and biospecimen tracking. It supports evolving trial technologies and best practices so researchers can conduct studies more efficiently and safely. Patients may benefit indirectly through more reliable trial findings and faster access to advanced therapies. The center has a long history of adapting from paper-based processes to modern, secure electronic systems to protect participant information.
Why it matters
Potential benefit: If successful, it could improve the safety, quality, and speed of clinical trials for allergic and autoimmune diseases, leading to better treatments sooner.
How similar studies have gone: Previous efforts have successfully modernized trial data management and safety systems, with ongoing improvements in data integrity and efficiency.
Where this research is happening
-
Rho Federal Systems Division, INC.
Durham, United States Active
Researchers
- Principal investigator: Dunaway, Lars — Rho Federal Systems Division, INC.
- Study coordinator: Dunaway, Lars
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.